BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19037040)

  • 1. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial.
    Winikoff B; Dzuba IG; Creinin MD; Crowden WA; Goldberg AB; Gonzales J; Howe M; Moskowitz J; Prine L; Shannon CS
    Obstet Gynecol; 2008 Dec; 112(6):1303-1310. PubMed ID: 19037040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion.
    Chong E; Tsereteli T; Nguyen NN; Winikoff B
    Contraception; 2012 Sep; 86(3):251-6. PubMed ID: 22305917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
    Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA;
    Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending outpatient medical abortion services through 70 days of gestational age.
    Winikoff B; Dzuba IG; Chong E; Goldberg AB; Lichtenberg ES; Ball C; Dean G; Sacks D; Crowden WA; Swica Y
    Obstet Gynecol; 2012 Nov; 120(5):1070-6. PubMed ID: 23090524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days.
    Fjerstad M; Sivin I; Lichtenberg ES; Trussell J; Cleland K; Cullins V
    Contraception; 2009 Sep; 80(3):282-6. PubMed ID: 19698822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation.
    Chai J; Wong CY; Ho PC
    Contraception; 2013 Apr; 87(4):480-5. PubMed ID: 23102797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.
    Lohr PA; Reeves MF; Hayes JL; Harwood B; Creinin MD
    Contraception; 2007 Sep; 76(3):215-20. PubMed ID: 17707719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
    Bracken H; Dabash R; Tsertsvadze G; Posohova S; Shah M; Hajri S; Mundle S; Chelli H; Zeramdini D; Tsereteli T; Platais I; Winikoff B
    Contraception; 2014 Mar; 89(3):181-6. PubMed ID: 24332431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
    Goldstone P; Michelson J; Williamson E
    Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone and misoprostol for early abortion when no gestational sac is present.
    Schaff EA; Fielding SL; Eisinger S; Stadalius L
    Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
    Dahiya K; Mann S; Nanda S
    Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol.
    Raghavan S; Comendant R; Digol I; Ungureanu S; Friptu V; Bracken H; Winikoff B
    Contraception; 2009 Feb; 79(2):84-90. PubMed ID: 19135563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.
    Schaff EA; Fielding SL; Westhoff C
    Contraception; 2002 Oct; 66(4):247-50. PubMed ID: 12413620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomised trial.
    Creinin MD; Schwartz JL; Pymar HC; Fink W
    BJOG; 2001 May; 108(5):469-73. PubMed ID: 11368131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
    Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
    Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro].
    Stojnić J; Ljubić A; Jeremić K; Radunović N; Tulić I; Bosković V; Dukanac J
    Vojnosanit Pregl; 2006 Jun; 63(6):558-63. PubMed ID: 16796021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.